Previous Article | Next Article 
J Virol, March 1998, p. 1862-1869, Vol. 72, No. 3
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Multiple Functions within the Epstein-Barr Virus EBNA-3A
Protein
Isabelle
Cludts1 and
Paul J.
Farrell1,2,*
Ludwig Institute for Cancer
Research1 and
Virology and Cell
Biology,2 Imperial College School of
Medicine at St. Mary's, London W2 1PG, United Kingdom
Received 5 September 1997/Accepted 4 December 1997
Two regions of the EBNA-3A protein of Epstein-Barr virus were shown
to be capable of binding to the cell protein RBP-Jk (also known as
CBF-1), a component of the Notch signaling pathway. Consistent with
this binding, EBNA-3A inhibited reporter gene expression from plasmids
containing RBP-Jk DNA binding sites within their promoters, including
the Cp promoter. When EBNA-3A was linked to a GAL4 DNA binding domain,
it repressed the activity of a promoter containing GAL4 binding sites
at all plasmid concentrations tested. However, a deletion mutant of
EBNA-3A lacking amino acids 100 to 364 showed a biphasic response in
the GAL4 assay: it inhibited transcription at low DNA concentrations
but activated it at high DNA concentrations. There appears to be a gene
activation function within EBNA-3A that is masked in the full-length
protein in this assay. Current models for EBNA-3 function have stressed
transcription repression through binding to RBP-Jk, but we consider an
alternative scheme in which the role of the binding of EBNA-3A, -3B,
and -3C to RBP-Jk is to buffer the levels of active EBNA-3 protein. We have also found that the behavior of EBNA-3A in a cell fractionation procedure that distinguishes insoluble matrix from soluble cell fractions is modified by EBNA-LP, indicating a further novel level of
interplay between the EBNA proteins.
*
Corresponding author. Mailing address: Ludwig Institute
for Cancer Research, Imperial College School of Medicine at St.
Mary's, Norfolk Place, London W2 1PG, United Kingdom. Phone:
44-171-724-5522. Fax: 44-171-724-8586. E-mail:
p.farrell{at}ic.ac.uk.
This article has been cited by other articles:
-
Lee, S., Sakakibara, S., Maruo, S., Zhao, B., Calderwood, M. A., Holthaus, A. M., Lai, C.-Y., Takada, K., Kieff, E., Johannsen, E.
(2009). Epstein-Barr Virus Nuclear Protein 3C Domains Necessary for Lymphoblastoid Cell Growth: Interaction with RBP-J{kappa} Regulates TCL1. J. Virol.
83: 12368-12377
[Abstract]
[Full Text]
-
Young, P., Anderton, E., Paschos, K., White, R., Allday, M. J.
(2008). Epstein-Barr virus nuclear antigen (EBNA) 3A induces the expression of and interacts with a subset of chaperones and co-chaperones. J. Gen. Virol.
89: 866-877
[Abstract]
[Full Text]
-
Buck, M., Burgess, A., Stirzaker, R., Krauer, K., Sculley, T.
(2006). Epstein-Barr virus nuclear antigen 3A contains six nuclear-localization signals.. J. Gen. Virol.
87: 2879-2884
[Abstract]
[Full Text]
-
Maruo, S., Johannsen, E., Illanes, D., Cooper, A., Zhao, B., Kieff, E.
(2005). Epstein-Barr Virus Nuclear Protein 3A Domains Essential for Growth of Lymphoblasts: Transcriptional Regulation through RBP-J{kappa}/CBF1 Is Critical. J. Virol.
79: 10171-10179
[Abstract]
[Full Text]
-
Touitou, R., O'Nions, J., Heaney, J., Allday, M. J.
(2005). Epstein-Barr virus EBNA3 proteins bind to the C8/{alpha}7 subunit of the 20S proteasome and are degraded by 20S proteasomes in vitro, but are very stable in latently infected B cells. J. Gen. Virol.
86: 1269-1277
[Abstract]
[Full Text]
-
Maruo, S., Johannsen, E., Illanes, D., Cooper, A., Kieff, E.
(2003). Epstein-Barr Virus Nuclear Protein EBNA3A Is Critical for Maintaining Lymphoblastoid Cell Line Growth. J. Virol.
77: 10437-10447
[Abstract]
[Full Text]
-
Cooper, A., Johannsen, E., Maruo, S., Cahir-McFarland, E., Illanes, D., Davidson, D., Kieff, E.
(2002). EBNA3A Association with RBP-J{kappa} Down-Regulates c-myc and Epstein-Barr Virus-Transformed Lymphoblast Growth. J. Virol.
77: 999-1010
[Abstract]
[Full Text]
-
Hickabottom, M., Parker, G. A., Freemont, P., Crook, T., Allday, M. J.
(2002). Two Nonconsensus Sites in the Epstein-Barr Virus Oncoprotein EBNA3A Cooperate to Bind the Co-repressor Carboxyl-terminal-binding Protein (CtBP). J. Biol. Chem.
277: 47197-47204
[Abstract]
[Full Text]
-
Pajic, A., Polack, A., Staege, M. S., Spitkovsky, D., Baier, B., Bornkamm, G. W., Laux, G.
(2001). Elevated expression of c-myc in lymphoblastoid cells does not support an Epstein-Barr virus latency III-to-I switch. J. Gen. Virol.
82: 3051-3055
[Abstract]
[Full Text]
-
Dufva, M., Olsson, M., Rymo, L.
(2001). Epstein-Barr virus nuclear antigen 5 interacts with HAX-1, a possible component of the B-cell receptor signalling pathway. J. Gen. Virol.
82: 1581-1587
[Abstract]
[Full Text]
-
Pokrovskaja, K., Mattsson, K., Kashuba, E., Klein, G., Szekely, L.
(2001). Proteasome inhibitor induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5. J. Gen. Virol.
82: 345-358
[Abstract]
[Full Text]
-
Dalbiès-Tran, R., Stigger-Rosser, E., Dotson, T., Sample, C. E.
(2001). Amino Acids of Epstein-Barr Virus Nuclear Antigen 3A Essential for Repression of J{kappa}-Mediated Transcription and Their Evolutionary Conservation. J. Virol.
75: 90-99
[Abstract]
[Full Text]
-
Jiang, H., Cho, Y.-g., Wang, F.
(2000). Structural, Functional, and Genetic Comparisons of Epstein-Barr Virus Nuclear Antigen 3A, 3B, and 3C Homologues Encoded by the Rhesus Lymphocryptovirus. J. Virol.
74: 5921-5932
[Abstract]
[Full Text]
-
Spender, L. C., Cannell, E. J., Hollyoake, M., Wensing, B., Gawn, J. M., Brimmell, M., Packham, G., Farrell, P. J.
(1999). Control of Cell Cycle Entry and Apoptosis in B Lymphocytes Infected by Epstein-Barr Virus. J. Virol.
73: 4678-4688
[Abstract]
[Full Text]